IP Library Granted Patent US 12,042,589
Granted Patent B2
US 12,042,589 · App. 17/993,302 · Granted Jul 23, 2024

Dialysis systems and methods including sensor feedback to improve patient experience

Inventors: Sukhraaj Basati (Bartlett, IL); Shantanu Avinash Gadre (Palatine, IL); Mohammad Ali Jamnia (Pleasant Prairie, WI); Lakshmy M. Nair (Vernon Hills, IL); William J. O'Reilly (Waukesha, WI); Marta Wlodarczyk (Arlington Heights, IL)
Assignees: Baxter International Inc.; Baxter Healthcare SA
A61M1/284A61M1/1524A61M1/154A61M1/155A61M1/1561A61M1/1565A61M1/159A61M1/285A61M1/287A61M1/166A61M1/288A61M2205/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,042,589
App. No.
17/993,302
Granted
Jul 23, 2024
Kind
B2
Abstract

A peritoneal dialysis system for detecting peritonitis is disclosed herein. In one example, an impedance measurement system includes an impedance monitor configured to sense an impedance of peritoneal dialysis (“PD”) fluid residing within a fluid line. The impedance monitor includes a first conductive lead disposed within a first port along the fluid line and a second conductive lead disposed within a second port along the fluid line. The impedance measurement system also includes a control unit electrically coupled to the impedance monitor. The control unit uses the sensed impedance from the impedance monitor to detect white blood cells to form a patient peritonitis determination. The control unit may communicate the peritonitis determination to alert a clinician.

Claims (36)

1. An impedance measurement system comprising:

an impedance monitor configured to sense an impedance of peritoneal dialysis (“PD”) fluid residing within a fluid line, the impedance monitor including

a first conductive lead disposed within a first port along the fluid line, and

a second conductive lead disposed within a second port along the fluid line; and

a control unit electrically coupled to the impedance monitor and configured to

use the sensed impedance from the impedance monitor to detect white blood cells to form a patient peritonitis determination, and

communicate the peritonitis determination.

2. The impedance measurement system of claim 1 , wherein the first conductive lead and the second conductive lead are located within a fluid connector configured to couple to the fluid line.

3. The impedance measurement system of claim 2 , wherein the fluid connector is configured to be spliced between two sections of the fluid line.

4. The impedance measurement system of claim 1 , wherein the first conductive lead is coupled to a first cylindrical electrode disposed within the fluid line, and wherein the second conductive lead is coupled to a second cylindrical electrode disposed within the fluid line.

5. The impedance measurement system of claim 1 , wherein the first conductive lead and the second conductive lead extend from the fluid line to (i) the control unit, (ii) a control unit of a water purifier configured to supply purified water to a disposable set, or (iii) a wireless module.

6. The impedance measurement system of claim 1 , wherein the sensed impedance is sent to the control unit wired or wirelessly.

7. The impedance measurement system of claim 1 , further comprising at least one doctor computer or clinician computer in communication with the control unit via a network, wherein the control unit is configured to communicate the peritonitis determination to the at least one doctor computer or clinician computer via the network.

8. The impedance measurement system of claim 1 , further comprising a user interface configured to:

receive the peritonitis determination from the control unit; and

display information indicative of the peritonitis determination.

9. The impedance measurement system of claim 8 , wherein the control unit and the user interface are included within a PD cycler.

10. The impedance measurement system of claim 1 , wherein the control unit is configured to analyze the sensed impedance of the PD fluid residing within the fluid line via a frequency sweep that moves from a start frequency to a stop frequency using the first and second conductive leads.

11. The impedance measurement system of claim 10 , wherein the frequency sweep is generated by a frequency generator provided by or operable with the control unit.

12. The impedance measurement system of claim 10 , wherein the control unit is configured to perform an impedance measurement at two or more frequencies of the frequency sweep.

13. The impedance measurement system of claim 10 , wherein the frequency sweep enables PD fluid having white blood cells to be determined by measuring, over at least a portion of the frequency sweep, higher impedances for PD fluid having white blood cells than impedances for PD fluid not having white blood cells.

14. The impedance measurement system of claim 13 , wherein the impedances for PD fluid not having white blood cells (i) are determined based on set standard impedances, or (ii) are determined based on impedances established for the patient.

15. The impedance measurement system of claim 10 , wherein the frequency sweep enables PD fluid having white blood cells to be distinguished from PD fluid having fibrin, wherein the PD fluid having fibrin yields higher impedances over at least a portion of the frequency sweep than the PD fluid having white blood cells.

16. The impedance measurement system of claim 1 , wherein the peritonitis determination is a first peritonitis indicator, and the control unit is configured to obtain at least one different peritonitis indicator useable in combination with the first peritonitis indicator to form an overall peritonitis determination.

17. The impedance measurement system of claim 16 , wherein the at least one different peritonitis indicator useable in combination with the first peritonitis indicator is obtained from at least one of a patient effluent PD fluid temperature sensor or a white blood cell biosensor.

18. The impedance measurement system of claim 1 , wherein the peritonitis determination is provided in combination with an insulin injection made using feedback from a patient effluent glucose biosensor.

19. An impedance measurement system comprising:

an impedance monitor configured to sense an impedance of peritoneal dialysis (“PD”) fluid residing within a fluid line, the impedance monitor including

a first conductive lead disposed within a first port along the fluid line, and

a second conductive lead disposed within a second port along the fluid line; and

a water purifier configured to supply purified water to a disposable set, the water purifier including a water purifier control unit that is configured to:

use the sensed impedance from the impedance monitor to detect white blood cells to form a patient peritonitis determination, and

communicate the peritonitis determination.

20. The impedance measurement system of claim 19 , further comprising a PD cycler configured to:

receive the peritonitis determination from the water purifier control unit; and

transmit the peritonitis determination to a clinician computer via a network.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 073413/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073438/0790 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2022
From: BASATI, SUKHRAAJ; GADRE, SHANTANU AVINASH; JAMNIA, MOHAMMAD ALI; NAIR, LAKSHMY M.; O'REILLY, WILLIAM J.; WLODARCZYK, MARTA
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 061910/0831 →